Effective targeting of PDGFRA-altered high-grade glioma with avapritinib
Cancer Cell · 2025-04 · 43 (4) · 740-756.e8
DOI: 10.1016/j.ccell.2025.02.018 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Cell, 2025-04. Verfasst von Lisa Mayr und 59 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Oncology, Dana-Farber/Boston Children's Cancer and Blood Disorder Center and Harvard Medical School, Boston, MA 02215, USA; D…. Hauptthemen laut MEDLINE: Glioma, Receptor, Platelet-Derived Growth Factor alpha, Brain Neoplasms, Pyrazoles. Die Arbeit wurde bisher 53-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIGMS NIH HHS, NCI NIH HHS, NINDS NIH HHS.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatric Oncology, Dana-Farber/Boston Children's Cancer and Blood Disorder Center and Harvard Medical School, Boston, MA 02215, USA; Department of Pediatrics and Adolescent Medicine, Comprehensive Center…
- Department of Pediatric Oncology, Dana-Farber/Boston Children's Cancer and Blood Disorder Center and Harvard Medical School, Boston, MA 02215, USA.
- Department of Pediatrics, University of Michigan Medical School, Ann Arbor, MI 48109, USA.
- Center for Neuropathology and Prion Research, Ludwig Maximilians University Munich, Faculty of Medicine, Muenchen, 80539 Bayern, Germany.
- Department of Pediatric Oncology, Dana-Farber/Boston Children's Cancer and Blood Disorder Center and Harvard Medical School, Boston, MA 02215, USA; St. Anna Children's Hospital, Department of Pediatrics and Adolescent M…
- Department of Pediatrics and Adolescent Medicine, Comprehensive Center for Pediatrics and Comprehensive Cancer Center, Medical University of Vienna, 1090 Vienna, Austria.
Förderung
- NIGMS NIH HHS
- NCI NIH HHS
- NINDS NIH HHS
- National Institutes of Health
- Pediatric Brain Tumor Foundation
- Dana-Farber Cancer Institute
- Ministerstvo Zdravotnictví Ceské Republiky
- Sontag Foundation
Zitieren
APA
Mayr, L., Neyazi, S., Schwark, K., Trissal, M., Beck, A., Labelle, J., Eder, S. K., Weiler-Wichtl, L., Marques, J. G., de Biagi-Junior, C. A. O., Lo Cascio, C., Chapman, O., Sridhar, S., Kenkre, R., Dutta, A., Wang, S., Wang, J., Hack, O., Nascimento, A., …, & Beroukhim, R. (2025). Effective targeting of PDGFRA-altered high-grade glioma with avapritinib. Cancer Cell, 43(4), 740-756.e8. https://doi.org/10.1016/j.ccell.2025.02.018
Vancouver
Mayr L, Neyazi S, Schwark K, Trissal M, Beck A, Labelle J, et al. Effective targeting of PDGFRA-altered high-grade glioma with avapritinib. Cancer Cell. 2025;43(4):740-756.e8. doi:10.1016/j.ccell.2025.02.018
BibTeX
@article{Mayr2025,
author = {Mayr, Lisa and Neyazi, Sina and Schwark, Kallen and Trissal, Maria and Beck, Alexander and Labelle, Jenna and Eder, Sebastian K and Weiler-Wichtl, Liesa and Marques, Joana G and de Biagi-Junior, Carlos A O and Lo Cascio, Costanza and Chapman, Owen and Sridhar, Sunita and Kenkre, Rishaan and Dutta, Aditi and Wang, Shanqing and Wang, Jessica and Hack, Olivia and Nascimento, Andrezza and Nguyen, Cuong M and Castellani, Sophia and Rozowsky, Jacob S and Groves, Andrew and Panditharatna, Eshini and Cruzeiro, Gustavo Alencastro Veiga and Haase, Rebecca D and Tabatabai, Kuscha and Madlener, Sibylle and Wadden, Jack and Adam, Tiffany and Kong, Seongbae and Miclea, Madeline and Patel, Tirth and Bruckner, Katharina and Senfter, Daniel and Lämmerer, Anna and Supko, Jeffrey and Guntner, Armin S and Palova, Hana and Neradil, Jakub and Stepien, Natalia and Lötsch-Gojo, Daniela and Berger, Walter and Leiss, Ulrike and Rosenmayr, Verena and Dorfer, Christian and Dieckmann, Karin and Peyrl, Andreas and Azizi, Amedeo A and Baumgartner, Alicia and Slaby, Ondrej and Pokorna, Petra and Clark, Louise M and Cameron, Amy and Nguyen, Quang-De and Wakimoto, Hiroaki and Dubois, Frank and Greenwald, Noah F and Bandopadhayay, Pratiti and Beroukhim, Rameen},
title = {Effective targeting of PDGFRA-altered high-grade glioma with avapritinib},
journal = {Cancer Cell},
year = {2025},
volume = {43},
number = {4},
pages = {740--756.e8},
doi = {10.1016/j.ccell.2025.02.018}
}
EUVIMED